At the same time, simultaneous nanoparticle-mediated delivery of temozolomide, and OTX015, an epigenetic inhibitor of bromodomain-containing protein 4 (BRD4), can block the tumor expression of PD-L1 and make glioblastoma cells a target for chemotherapy and immunotherapy [125]. This evidence concerns the gene BRD4 and glioblastoma.